Nilogen Oncosystems

We are excited to announce that we will be attending SITC 2024! Nilogen Oncosystems provides a unique 3D ex-vivo platform to study the mechanism of action, safety, and efficacy of your innovative therapeutics. We work with freshly procured patient tumor tissue which is minimally processed to preserve the extracellular matrix and immune milieu, closely mirroring the immune milieu in the patients. Meet our scientific and BD teams to discuss how we can support your pre-clinical and clinical drug development efforts using our unique 3D ex vivo platform.   To learn more, please stop by Booth #928.  We look forward to meeting you in Houston.

We are excited to announce that we will be attending SITC 2024! Nilogen Oncosystems provides a unique 3D ex-vivo platform to study the mechanism of action, safety, and efficacy of your innovative therapeutics. We work with freshly procured patient tumor tissue which is minimally processed to preserve the extracellular matrix and immune milieu, closely mirroring the immune milieu in the patients. Meet our scientific and BD teams to discuss how we can support your pre-clinical and clinical drug development efforts using our unique 3D ex vivo platform.   To learn more, please stop by Booth #928.  We look forward to meeting you in Houston.

We are excited to announce that we will be attending SITC 2024! Nilogen Oncosystems provides a unique 3D ex-vivo platform to study the mechanism of action, safety, and efficacy of your innovative therapeutics. We work with freshly procured patient tumor tissue which is minimally processed to preserve the extracellular matrix and immune milieu, closely mirroring the immune milieu in the patients. Meet our scientific and BD teams to discuss how we can support your pre-clinical and clinical drug development efforts using our unique 3D ex-vivo platform.   To learn more, please stop by Booth #928.  We look forward to meeting you in Houston.

Make this summer a season of discovery with Nilogen’s 3D ex vivo technology. Get rapid, actionable results and accelerate your journey from discovery to clinical application. For more information, visit www.nilogen.com or contact us at BD@nilogen.com.

Join us for a special LinkedIn Live interview on June 19 at 9 am PDT with Rikhia Chakraborty, Nilogen Oncosystems’ CSO. Explore the forefront of cancer technology with insights into our tumoroid platforms and discover how Nilogen is shaping the future of immuno-oncology, improving clinical outcome predictability. In conversation with Hersh Ashish Chaturvedi, VP with Strategic Partnerships, we will dive into the complexities of maintaining the tumor microenvironment and harnessing AI in biomedical research. Save the date and don't miss this exclusive opportunity to learn about the cutting-edge technologies in cancer research! #NilogenOncosystems #CancerResearch #Immunotherapy #BiomedicalInnovation #LinkedInLive #HealthcareTechnology #Tumoroidplatforms https://lnkd.in/gWN6btdp

We're thrilled to announce our participation at ASCO 2024! Visit us at Booth #35094 to discover why our advanced tumoroid platform is revolutionizing preclinical studies. 🔬 Why Tumoroids? Tumoroids offer a cutting-edge alternative to traditional 3D systems, providing more realistic models that closely mimic human cancer environments. This leap in technology enables more accurate and predictive analyses, setting a new standard for oncology research. 🤝 Meet Our Experts: Drop by to chat with our representatives William Coward, Jared Ehrhart, and Carlo Petruzziello. They're eager to share insights and discuss how Nilogen's innovative solutions can accelerate your research. Don't miss the opportunity to learn about the future of preclinical studies with us at ASCO 2024. See you there! #ASCO2024

#AACR2024 #nilogenoncosystems #exvivotumormodel POSTER NUMBER #6782

Exciting news! Nilogen Oncosystems is thrilled to announce our presence at AACR 2024! 🎉 We cordially invite you to visit our booth to discover more about our groundbreaking advancements in oncology research. Learn firsthand about our innovative approaches and cutting-edge solutions aimed at revolutionizing cancer therapeutics. Don't miss this opportunity to engage with our team and explore the future of oncology. See you there! #AACR2024 #OncologyResearch #3dcancermodel #precisiononcology #NilogenOncosystems

I’m #hiring. Know anyone who might be interested? 👋😊